HEADER CHAPERONE 10-MAY-10 2XDX TITLE STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 9-236; COMPND 5 SYNONYM: HEAT SHOCK 86 KDA, HSP86, RENAL CARCINOMA ANTIGEN NY-REN- COMPND 6 38HSP90; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS CHAPERONE, INHIBITOR, STRESS RESPONSE EXPDTA X-RAY DIFFRACTION AUTHOR C.W.MURRAY,M.G.CARR,O.CALLAGHAN,G.CHESSARI,M.CONGREVE,S.COWAN, AUTHOR 2 J.E.COYLE,R.DOWNHAM,E.FIGUEROA,M.FREDERICKSON,B.GRAHAM,R.MCMENAMIN, AUTHOR 3 M.A.O'BRIEN,S.PATEL,T.R.PHILLIPS,G.WILLIAMS,A.J.WOODHEAD, AUTHOR 4 A.J.A.WOOLFORD REVDAT 3 08-MAY-24 2XDX 1 REMARK REVDAT 2 14-DEC-16 2XDX 1 TITLE AUTHOR REMARK VERSN REVDAT 1 01-SEP-10 2XDX 0 JRNL AUTH C.W.MURRAY,M.G.CARR,O.CALLAGHAN,G.CHESSARI,M.CONGREVE, JRNL AUTH 2 S.COWAN,J.E.COYLE,R.DOWNHAM,E.FIGUEROA,M.FREDERICKSON, JRNL AUTH 3 B.GRAHAM,R.MCMENAMIN,M.A.O'BRIEN,S.PATEL,T.R.PHILLIPS, JRNL AUTH 4 G.WILLIAMS,A.J.WOODHEAD,A.J.A.WOOLFORD JRNL TITL FRAGMENT-BASED DRUG DISCOVERY APPLIED TO HSP90. DISCOVERY OF JRNL TITL 2 TWO LEAD SERIES WITH HIGH LIGAND EFFICIENCY. JRNL REF J.MED.CHEM. V. 53 5942 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20718493 JRNL DOI 10.1021/JM100059D REMARK 2 REMARK 2 RESOLUTION. 2.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.5.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.7 REMARK 3 NUMBER OF REFLECTIONS : 7610 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.330 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 370 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.42 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.57 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.65 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 990 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2327 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 947 REMARK 3 BIN R VALUE (WORKING SET) : 0.2239 REMARK 3 BIN FREE R VALUE : 0.4497 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.34 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 43 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1678 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.02296 REMARK 3 B22 (A**2) : 2.51115 REMARK 3 B33 (A**2) : 0.51182 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 7.97995 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XDX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1290043872. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8264 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 32.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.96400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -12 REMARK 465 GLY A -11 REMARK 465 SER A -10 REMARK 465 SER A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 SER A -2 REMARK 465 SER A -1 REMARK 465 GLY A 0 REMARK 465 LEU A 1 REMARK 465 VAL A 2 REMARK 465 PRO A 3 REMARK 465 ARG A 4 REMARK 465 GLY A 5 REMARK 465 SER A 6 REMARK 465 HIS A 7 REMARK 465 MET A 8 REMARK 465 ASP A 9 REMARK 465 GLN A 10 REMARK 465 GLU A 225 REMARK 465 ARG A 226 REMARK 465 ASP A 227 REMARK 465 LYS A 228 REMARK 465 GLU A 229 REMARK 465 VAL A 230 REMARK 465 SER A 231 REMARK 465 ASP A 232 REMARK 465 ASP A 233 REMARK 465 GLU A 234 REMARK 465 ALA A 235 REMARK 465 GLU A 236 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 224 CA C O CB CG CD CE REMARK 470 LYS A 224 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 35 35.13 -95.30 REMARK 500 SER A 72 11.73 -69.71 REMARK 500 ARG A 87 46.41 72.81 REMARK 500 THR A 94 38.64 -95.54 REMARK 500 ALA A 166 -138.75 76.30 REMARK 500 GLU A 178 115.12 -30.54 REMARK 500 ARG A 182 137.35 -172.42 REMARK 500 PHE A 213 40.44 -91.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WOE A 1224 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CDD RELATED DB: PDB REMARK 900 HUMAN HSP90 WITH 4-(4-(2,3-DIHYDRO- BENZOL(1,4)DIOXIN-6-YL)-5- REMARK 900 METHYL-1H- PYRAZOL-3-YL)-6-ETHYL-BENZENE-1,3-DIOL REMARK 900 RELATED ID: 1YES RELATED DB: PDB REMARK 900 HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "OPEN " CONFORMATION REMARK 900 RELATED ID: 1UY9 RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-BENZO[1,3] DIOXOL-,5-YLMETHYL-9-BUTYL-9H- REMARK 900 PURIN-6- YLAMINE REMARK 900 RELATED ID: 1BYQ RELATED DB: PDB REMARK 900 HSP90 N-TERMINAL DOMAIN BOUND TO ADP-MG REMARK 900 RELATED ID: 2BSM RELATED DB: PDB REMARK 900 NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE REMARK 900 HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN REMARK 900 RELATED ID: 1OSF RELATED DB: PDB REMARK 900 HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY- 17-N,N- REMARK 900 DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN REMARK 900 RELATED ID: 2WI3 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 REMARK 900 CHAPERONE REMARK 900 RELATED ID: 1UY8 RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3- TRIMETHOXY-BENZYL)-9H-PURIN- REMARK 900 6YLAMINE REMARK 900 RELATED ID: 2BUG RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE TPR DOMAIN FROM PROTEIN PHOSPHATASE 5 IN REMARK 900 COMPLEX WITH HSP90 DERIVED PEPTIDE REMARK 900 RELATED ID: 2WI4 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 REMARK 900 CHAPERONE REMARK 900 RELATED ID: 2UWD RELATED DB: PDB REMARK 900 INHIBITION OF THE HSP90 MOLECULAR CHAPERONE IN VITRO AND IN VIVO BY REMARK 900 NOVEL, SYNTHETIC , POTENT RESORCINYLIC PYRAZOLE, ISOXAZOLE AMIDE REMARK 900 ANALOGS REMARK 900 RELATED ID: 2WI7 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 REMARK 900 CHAPERONE REMARK 900 RELATED ID: 2BT0 RELATED DB: PDB REMARK 900 NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE REMARK 900 HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN REMARK 900 RELATED ID: 1YER RELATED DB: PDB REMARK 900 HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, " CLOSED" CONFORMATION REMARK 900 RELATED ID: 2XDU RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 1UYG RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY- BENZYL)-2-FLUORO-9H-PURIN- REMARK 900 6-YLAMINE REMARK 900 RELATED ID: 2BZ5 RELATED DB: PDB REMARK 900 STRUCTURE-BASED DISCOVERY OF A NEW CLASS OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2CCU RELATED DB: PDB REMARK 900 HUMAN HSP90 WITH 4-CHLORO-6-(4-(4-(4- METHANESULPHONYL-BENZYL)- REMARK 900 PIERAZIN-1-YL)-1H- PYRAZOL-3-YL)-BENZENE-1,3-DIOL REMARK 900 RELATED ID: 2CCS RELATED DB: PDB REMARK 900 HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN- 1-YL-1H-PYRAZOL-3-YL)- REMARK 900 BENZENE-1,2-DIOL REMARK 900 RELATED ID: 1UYF RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4, 5-TRIMETHOXY-BENZYL)-2- REMARK 900 FLUORO-9-PENT-4- YLNYL-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1YC3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED REMARK 900 WITHDIHYDROXYPHENYLPYRAZOLES REMARK 900 RELATED ID: 1UYI RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY- BENZYL)-2-FLUORO-9-PENT-9H- REMARK 900 PURIN-6- YLAMINE REMARK 900 RELATED ID: 1UYD RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2- CHLORO-3,4,5-TRIMETHOXY-BENZYL) REMARK 900 -9H-PURIN- 6-YLAMINE REMARK 900 RELATED ID: 2BYI RELATED DB: PDB REMARK 900 3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE- 4-CARBOXAMIDES AS REMARK 900 INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE REMARK 900 RELATED ID: 2XDL RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2WI2 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 REMARK 900 CHAPERONE REMARK 900 RELATED ID: 1UY6 RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3,4, 5-TRIMETHOXY-BENZYL)-9H- REMARK 900 PURIN-6-YLAMINE REMARK 900 RELATED ID: 2VCI RELATED DB: PDB REMARK 900 4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL REMARK 900 THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER REMARK 900 RELATED ID: 2WI1 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 REMARK 900 CHAPERONE REMARK 900 RELATED ID: 2VCJ RELATED DB: PDB REMARK 900 4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL REMARK 900 THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER REMARK 900 RELATED ID: 1YC4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED REMARK 900 WITHDIHYDROXYPHENYLPYRAZOLES REMARK 900 RELATED ID: 2C2L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CHIP U-BOX E3 UBIQUITIN LIGASE REMARK 900 RELATED ID: 2FWZ RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT WATERSOLUBLE REMARK 900 INHIBITOR PU-H71 REMARK 900 RELATED ID: 2XDK RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 1UYH RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5- DIMETHOXY-BENZYL)-2-FLUORO- REMARK 900 9H-PURIN-6- YLAMINE REMARK 900 RELATED ID: 1UYK RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-BENZO[1,3] DIOXOL-,5-YLMETHYL-9-BUTYL-2- REMARK 900 FLUORO-9H- PURIN-6-YLAMINE REMARK 900 RELATED ID: 2CCT RELATED DB: PDB REMARK 900 HUMAN HSP90 WITH 5-(5-CHLORO-2,4- DIHYDROXY-PHENYL)-4-PIPERAZIN-1- REMARK 900 YL-2H- PYRAZOLE-3-CARBOXYLIC ACID ETHYLAMIDE REMARK 900 RELATED ID: 2FWY RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT WATERSOLUBLE REMARK 900 INHIBITOR PU-H64 REMARK 900 RELATED ID: 1UYL RELATED DB: PDB REMARK 900 STRUCTURE-ACTIVITY RELATIONSHIPS IN PURINE- BASED INHIBITOR BINDING REMARK 900 TO HSP90 ISOFORMS REMARK 900 RELATED ID: 1UYE RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4, 5-TRIMETHOXY-BENZYL)-9-PENT- REMARK 900 4-YLNYL-9H- PURIN-6-YLAMINE REMARK 900 RELATED ID: 2WI6 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 REMARK 900 CHAPERONE REMARK 900 RELATED ID: 2XAB RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH AN INHIBITOR BOUND REMARK 900 RELATED ID: 1YC1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HUMAN HSP90ALPHA COMPLEXED REMARK 900 WITHDIHYDROXYPHENYLPYRAZOLES REMARK 900 RELATED ID: 1UYC RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5- DIMETHOXY-BENZYL)-9H-PURIN-6- REMARK 900 YLAMINE REMARK 900 RELATED ID: 1UY7 RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(4- METHOXY-BENZYL)-9H-PURIN-6- REMARK 900 YLAMINE REMARK 900 RELATED ID: 1YET RELATED DB: PDB REMARK 900 GELDANAMYCIN BOUND TO THE HSP90 GELDANAMYCIN- BINDING DOMAIN REMARK 900 RELATED ID: 2JJC RELATED DB: PDB REMARK 900 HSP90 ALPHA ATPASE DOMAIN WITH BOUND SMALL MOLECULE FRAGMENT REMARK 900 RELATED ID: 2BYH RELATED DB: PDB REMARK 900 3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE- 4-CARBOXAMIDES AS REMARK 900 INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE REMARK 900 RELATED ID: 2WI5 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 REMARK 900 CHAPERONE REMARK 900 RELATED ID: 2XDS RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND DBREF 2XDX A 9 236 UNP P07900 HS90A_HUMAN 9 236 SEQADV 2XDX MET A -12 UNP P07900 EXPRESSION TAG SEQADV 2XDX GLY A -11 UNP P07900 EXPRESSION TAG SEQADV 2XDX SER A -10 UNP P07900 EXPRESSION TAG SEQADV 2XDX SER A -9 UNP P07900 EXPRESSION TAG SEQADV 2XDX HIS A -8 UNP P07900 EXPRESSION TAG SEQADV 2XDX HIS A -7 UNP P07900 EXPRESSION TAG SEQADV 2XDX HIS A -6 UNP P07900 EXPRESSION TAG SEQADV 2XDX HIS A -5 UNP P07900 EXPRESSION TAG SEQADV 2XDX HIS A -4 UNP P07900 EXPRESSION TAG SEQADV 2XDX HIS A -3 UNP P07900 EXPRESSION TAG SEQADV 2XDX SER A -2 UNP P07900 EXPRESSION TAG SEQADV 2XDX SER A -1 UNP P07900 EXPRESSION TAG SEQADV 2XDX GLY A 0 UNP P07900 EXPRESSION TAG SEQADV 2XDX LEU A 1 UNP P07900 EXPRESSION TAG SEQADV 2XDX VAL A 2 UNP P07900 EXPRESSION TAG SEQADV 2XDX PRO A 3 UNP P07900 EXPRESSION TAG SEQADV 2XDX ARG A 4 UNP P07900 EXPRESSION TAG SEQADV 2XDX GLY A 5 UNP P07900 EXPRESSION TAG SEQADV 2XDX SER A 6 UNP P07900 EXPRESSION TAG SEQADV 2XDX HIS A 7 UNP P07900 EXPRESSION TAG SEQADV 2XDX MET A 8 UNP P07900 EXPRESSION TAG SEQRES 1 A 249 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 249 LEU VAL PRO ARG GLY SER HIS MET ASP GLN PRO MET GLU SEQRES 3 A 249 GLU GLU GLU VAL GLU THR PHE ALA PHE GLN ALA GLU ILE SEQRES 4 A 249 ALA GLN LEU MET SER LEU ILE ILE ASN THR PHE TYR SER SEQRES 5 A 249 ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SER SEQRES 6 A 249 SER ASP ALA LEU ASP LYS ILE ARG TYR GLU SER LEU THR SEQRES 7 A 249 ASP PRO SER LYS LEU ASP SER GLY LYS GLU LEU HIS ILE SEQRES 8 A 249 ASN LEU ILE PRO ASN LYS GLN ASP ARG THR LEU THR ILE SEQRES 9 A 249 VAL ASP THR GLY ILE GLY MET THR LYS ALA ASP LEU ILE SEQRES 10 A 249 ASN ASN LEU GLY THR ILE ALA LYS SER GLY THR LYS ALA SEQRES 11 A 249 PHE MET GLU ALA LEU GLN ALA GLY ALA ASP ILE SER MET SEQRES 12 A 249 ILE GLY GLN PHE GLY VAL GLY PHE TYR SER ALA TYR LEU SEQRES 13 A 249 VAL ALA GLU LYS VAL THR VAL ILE THR LYS HIS ASN ASP SEQRES 14 A 249 ASP GLU GLN TYR ALA TRP GLU SER SER ALA GLY GLY SER SEQRES 15 A 249 PHE THR VAL ARG THR ASP THR GLY GLU PRO MET GLY ARG SEQRES 16 A 249 GLY THR LYS VAL ILE LEU HIS LEU LYS GLU ASP GLN THR SEQRES 17 A 249 GLU TYR LEU GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS SEQRES 18 A 249 LYS HIS SER GLN PHE ILE GLY TYR PRO ILE THR LEU PHE SEQRES 19 A 249 VAL GLU LYS GLU ARG ASP LYS GLU VAL SER ASP ASP GLU SEQRES 20 A 249 ALA GLU HET WOE A1224 16 HETNAM WOE 4-CHLORO-6-(2-METHOXYPHENYL)PYRIMIDIN-2-AMINE FORMUL 2 WOE C11 H10 CL N3 O FORMUL 3 HOH *113(H2 O) HELIX 1 1 GLN A 23 ASN A 35 1 13 HELIX 2 2 GLU A 42 LEU A 64 1 23 HELIX 3 3 ASP A 66 ASP A 71 5 6 HELIX 4 4 THR A 99 LEU A 107 1 9 HELIX 5 5 GLY A 114 ALA A 124 1 11 HELIX 6 6 ASP A 127 GLY A 135 5 9 HELIX 7 7 VAL A 136 LEU A 143 5 8 HELIX 8 8 GLU A 192 LEU A 198 5 7 HELIX 9 9 GLU A 199 SER A 211 1 13 SHEET 1 AA 8 GLU A 18 ALA A 21 0 SHEET 2 AA 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 AA 8 GLN A 159 SER A 164 -1 O ALA A 161 N ARG A 173 SHEET 4 AA 8 ALA A 145 LYS A 153 -1 O VAL A 148 N SER A 164 SHEET 5 AA 8 GLY A 183 LEU A 190 -1 O GLY A 183 N LYS A 153 SHEET 6 AA 8 THR A 88 ASP A 93 -1 O LEU A 89 N LEU A 188 SHEET 7 AA 8 ILE A 78 ASN A 83 -1 O ASN A 79 N VAL A 92 SHEET 8 AA 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SITE 1 AC1 13 ASN A 51 SER A 52 ALA A 55 ASP A 93 SITE 2 AC1 13 ILE A 96 GLY A 97 MET A 98 ASN A 106 SITE 3 AC1 13 LEU A 107 PHE A 138 THR A 184 HOH A2029 SITE 4 AC1 13 HOH A2054 CRYST1 52.439 43.928 53.080 90.00 114.38 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019070 0.000000 0.008642 0.00000 SCALE2 0.000000 0.022765 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020684 0.00000 TER 1679 LYS A 224 HETATM 1680 C1 WOE A1224 7.843 1.196 11.388 1.00 36.90 C HETATM 1681 O2 WOE A1224 7.152 0.069 10.844 1.00 30.97 O HETATM 1682 C3 WOE A1224 6.611 0.198 9.591 1.00 14.71 C HETATM 1683 C4 WOE A1224 6.084 1.372 9.078 1.00 10.33 C HETATM 1684 C5 WOE A1224 5.559 1.395 7.806 1.00 14.70 C HETATM 1685 C6 WOE A1224 5.589 0.253 7.022 1.00 19.02 C HETATM 1686 C7 WOE A1224 6.120 -0.924 7.520 1.00 12.81 C HETATM 1687 C8 WOE A1224 6.651 -0.965 8.802 1.00 10.89 C HETATM 1688 C9 WOE A1224 7.211 -2.240 9.309 1.00 3.04 C HETATM 1689 C10 WOE A1224 8.114 -2.986 8.592 1.00 10.04 C HETATM 1690 C11 WOE A1224 8.554 -4.175 9.147 1.00 21.62 C HETATM 1691 CL1 WOE A1224 9.671 -5.173 8.268 1.00 30.49 CL HETATM 1692 N13 WOE A1224 8.169 -4.623 10.349 1.00 19.19 N HETATM 1693 C14 WOE A1224 7.272 -3.821 11.000 1.00 19.83 C HETATM 1694 N15 WOE A1224 6.841 -4.223 12.252 1.00 16.55 N HETATM 1695 N16 WOE A1224 6.798 -2.635 10.526 1.00 12.90 N HETATM 1696 O HOH A2001 31.596 4.820 28.028 1.00 28.53 O HETATM 1697 O HOH A2002 28.513 11.218 11.870 1.00 15.57 O HETATM 1698 O HOH A2003 27.426 5.368 14.360 1.00 18.66 O HETATM 1699 O HOH A2004 25.985 7.399 6.923 1.00 28.43 O HETATM 1700 O HOH A2005 25.162 10.001 6.500 1.00 39.97 O HETATM 1701 O HOH A2006 19.177 14.550 16.961 1.00 26.86 O HETATM 1702 O HOH A2007 13.571 12.966 4.728 1.00 29.11 O HETATM 1703 O HOH A2008 8.367 17.519 1.467 1.00 26.85 O HETATM 1704 O HOH A2009 -11.359 8.755 23.654 1.00 22.85 O HETATM 1705 O HOH A2010 0.840 19.643 0.158 1.00 23.87 O HETATM 1706 O HOH A2011 3.955 19.926 9.444 1.00 16.17 O HETATM 1707 O HOH A2012 -1.025 19.543 9.360 1.00 25.92 O HETATM 1708 O HOH A2013 -2.424 20.693 13.063 1.00 22.01 O HETATM 1709 O HOH A2014 -0.935 15.676 22.193 1.00 18.58 O HETATM 1710 O HOH A2015 15.434 15.551 16.717 1.00 25.19 O HETATM 1711 O HOH A2016 -4.992 12.748 19.647 1.00 22.36 O HETATM 1712 O HOH A2017 -7.892 19.183 13.210 1.00 25.63 O HETATM 1713 O HOH A2018 7.119 -22.718 16.335 1.00 33.69 O HETATM 1714 O HOH A2019 -12.460 10.912 16.021 1.00 22.54 O HETATM 1715 O HOH A2020 -12.629 0.524 17.666 1.00 24.85 O HETATM 1716 O HOH A2021 -12.929 0.532 14.584 1.00 26.42 O HETATM 1717 O HOH A2022 -14.383 5.449 19.940 1.00 26.42 O HETATM 1718 O HOH A2023 -9.202 6.539 22.247 1.00 18.97 O HETATM 1719 O HOH A2024 -10.021 3.972 21.624 1.00 26.83 O HETATM 1720 O HOH A2025 -6.035 -2.114 17.962 1.00 16.61 O HETATM 1721 O HOH A2026 -3.652 -6.200 13.424 1.00 12.58 O HETATM 1722 O HOH A2027 -4.741 -2.814 10.450 1.00 21.37 O HETATM 1723 O HOH A2028 3.239 5.126 -5.687 1.00 22.30 O HETATM 1724 O HOH A2029 4.955 -0.844 12.289 1.00 7.29 O HETATM 1725 O HOH A2030 5.769 -4.465 6.966 1.00 15.10 O HETATM 1726 O HOH A2031 5.684 14.861 -3.810 1.00 34.08 O HETATM 1727 O HOH A2032 -11.459 18.881 11.498 1.00 35.54 O HETATM 1728 O HOH A2033 3.363 -3.739 4.852 1.00 22.34 O HETATM 1729 O HOH A2034 -0.180 -3.458 7.412 1.00 26.24 O HETATM 1730 O HOH A2035 -14.143 4.920 9.823 1.00 32.84 O HETATM 1731 O HOH A2036 8.222 12.289 32.936 1.00 21.80 O HETATM 1732 O HOH A2037 15.354 -10.472 1.411 1.00 32.19 O HETATM 1733 O HOH A2038 19.272 -15.576 1.898 1.00 44.87 O HETATM 1734 O HOH A2039 13.981 13.461 16.296 1.00 13.60 O HETATM 1735 O HOH A2040 9.170 -18.479 22.485 1.00 35.32 O HETATM 1736 O HOH A2041 7.391 -20.544 14.020 1.00 38.19 O HETATM 1737 O HOH A2042 4.773 -14.563 20.586 1.00 16.29 O HETATM 1738 O HOH A2043 11.032 -11.867 20.188 1.00 25.14 O HETATM 1739 O HOH A2044 7.019 -15.866 22.917 1.00 24.69 O HETATM 1740 O HOH A2045 10.764 -9.898 23.177 1.00 4.19 O HETATM 1741 O HOH A2046 3.322 -4.943 32.832 1.00 4.90 O HETATM 1742 O HOH A2047 4.553 -3.015 33.566 1.00 17.78 O HETATM 1743 O HOH A2048 2.823 4.137 34.097 1.00 26.69 O HETATM 1744 O HOH A2049 11.022 -3.237 37.129 1.00 20.65 O HETATM 1745 O HOH A2050 4.573 -2.983 37.192 1.00 32.57 O HETATM 1746 O HOH A2051 7.681 6.534 28.256 1.00 25.33 O HETATM 1747 O HOH A2052 7.685 -1.385 27.438 1.00 32.19 O HETATM 1748 O HOH A2053 6.920 -4.395 15.747 1.00 12.67 O HETATM 1749 O HOH A2054 10.116 -6.874 11.082 1.00 14.79 O HETATM 1750 O HOH A2055 18.306 -4.139 9.268 1.00 9.85 O HETATM 1751 O HOH A2056 19.425 -0.336 2.505 1.00 21.58 O HETATM 1752 O HOH A2057 20.518 2.513 2.468 1.00 21.52 O HETATM 1753 O HOH A2058 14.903 -1.248 -0.567 1.00 23.51 O HETATM 1754 O HOH A2059 12.640 3.190 -3.523 1.00 39.58 O HETATM 1755 O HOH A2060 9.353 -2.847 5.011 1.00 26.05 O HETATM 1756 O HOH A2061 5.740 2.478 4.113 1.00 25.14 O HETATM 1757 O HOH A2062 7.988 7.675 3.959 1.00 14.99 O HETATM 1758 O HOH A2063 -0.058 11.944 -0.541 1.00 8.86 O HETATM 1759 O HOH A2064 2.929 5.042 -2.291 1.00 21.16 O HETATM 1760 O HOH A2065 3.848 17.259 -3.103 1.00 34.93 O HETATM 1761 O HOH A2066 -3.564 11.001 -1.564 1.00 27.10 O HETATM 1762 O HOH A2067 -5.591 17.254 -0.663 1.00 26.10 O HETATM 1763 O HOH A2068 -8.866 17.877 11.120 1.00 28.66 O HETATM 1764 O HOH A2069 -16.073 10.904 6.130 1.00 24.25 O HETATM 1765 O HOH A2070 -11.503 8.932 15.403 1.00 7.24 O HETATM 1766 O HOH A2071 -14.640 7.044 8.482 1.00 10.69 O HETATM 1767 O HOH A2072 -14.574 5.805 17.415 1.00 25.67 O HETATM 1768 O HOH A2073 -11.511 0.883 9.630 1.00 26.09 O HETATM 1769 O HOH A2074 -0.142 5.816 1.205 1.00 25.99 O HETATM 1770 O HOH A2075 2.152 1.725 8.100 1.00 23.29 O HETATM 1771 O HOH A2076 6.382 6.934 5.982 1.00 17.43 O HETATM 1772 O HOH A2077 3.031 12.628 28.036 1.00 25.09 O HETATM 1773 O HOH A2078 6.625 8.561 27.840 1.00 14.78 O HETATM 1774 O HOH A2079 7.804 10.962 30.522 1.00 31.70 O HETATM 1775 O HOH A2080 14.695 10.067 23.329 1.00 18.36 O HETATM 1776 O HOH A2081 15.841 -11.305 4.566 1.00 18.07 O HETATM 1777 O HOH A2082 21.867 -11.971 8.086 1.00 21.19 O HETATM 1778 O HOH A2083 15.730 -10.351 7.253 1.00 17.58 O HETATM 1779 O HOH A2084 25.103 -7.276 8.146 1.00 22.26 O HETATM 1780 O HOH A2085 21.900 -5.797 16.641 1.00 46.52 O HETATM 1781 O HOH A2086 9.116 13.281 23.214 1.00 10.03 O HETATM 1782 O HOH A2087 13.151 12.015 19.737 1.00 20.86 O HETATM 1783 O HOH A2088 11.211 14.081 16.801 1.00 9.51 O HETATM 1784 O HOH A2089 11.395 17.933 16.688 1.00 38.13 O HETATM 1785 O HOH A2090 4.374 17.370 14.882 1.00 14.91 O HETATM 1786 O HOH A2091 14.817 17.890 10.829 1.00 20.81 O HETATM 1787 O HOH A2092 17.219 7.015 16.749 1.00 8.98 O HETATM 1788 O HOH A2093 20.823 11.676 20.160 1.00 22.04 O HETATM 1789 O HOH A2094 19.777 2.961 21.758 1.00 23.49 O HETATM 1790 O HOH A2095 22.404 -4.184 18.223 1.00 25.57 O HETATM 1791 O HOH A2096 22.763 1.573 23.488 1.00 24.97 O HETATM 1792 O HOH A2097 18.299 -6.051 29.576 1.00 29.86 O HETATM 1793 O HOH A2098 19.337 -12.391 19.552 1.00 28.02 O HETATM 1794 O HOH A2099 13.562 3.324 24.249 1.00 19.70 O HETATM 1795 O HOH A2100 -4.149 12.024 32.726 1.00 25.34 O HETATM 1796 O HOH A2101 -0.427 9.241 33.947 1.00 24.57 O HETATM 1797 O HOH A2102 -1.463 13.810 26.612 1.00 30.05 O HETATM 1798 O HOH A2103 -7.624 10.144 24.771 1.00 25.14 O HETATM 1799 O HOH A2104 -5.155 5.847 29.776 1.00 19.50 O HETATM 1800 O HOH A2105 -7.152 6.043 23.906 1.00 29.20 O HETATM 1801 O HOH A2106 1.122 -4.656 32.437 1.00 12.65 O HETATM 1802 O HOH A2107 -7.520 -3.448 34.145 1.00 27.44 O HETATM 1803 O HOH A2108 -6.566 -10.748 23.797 1.00 24.09 O HETATM 1804 O HOH A2109 -10.532 -3.247 29.399 1.00 16.35 O HETATM 1805 O HOH A2110 -5.178 -4.573 18.112 1.00 17.44 O HETATM 1806 O HOH A2111 -7.794 -9.705 13.044 1.00 34.40 O HETATM 1807 O HOH A2112 3.195 -19.472 11.179 1.00 35.63 O HETATM 1808 O HOH A2113 2.707 -4.848 36.819 1.00 30.13 O CONECT 1680 1681 CONECT 1681 1680 1682 CONECT 1682 1681 1683 1687 CONECT 1683 1682 1684 CONECT 1684 1683 1685 CONECT 1685 1684 1686 CONECT 1686 1685 1687 CONECT 1687 1682 1686 1688 CONECT 1688 1687 1689 1695 CONECT 1689 1688 1690 CONECT 1690 1689 1691 1692 CONECT 1691 1690 CONECT 1692 1690 1693 CONECT 1693 1692 1694 1695 CONECT 1694 1693 CONECT 1695 1688 1693 MASTER 424 0 1 9 8 0 4 6 1807 1 16 20 END